BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16720240)

  • 1. Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.
    Hanaoka H; Mukai T; Tamamura H; Mori T; Ishino S; Ogawa K; Iida Y; Doi R; Fujii N; Saji H
    Nucl Med Biol; 2006 May; 33(4):489-94. PubMed ID: 16720240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors.
    Hanaoka H; Mukai T; Habashita S; Asano D; Ogawa K; Kuroda Y; Akizawa H; Iida Y; Endo K; Saga T; Saji H
    Nucl Med Biol; 2007 Jul; 34(5):503-10. PubMed ID: 17591550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
    Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
    J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13.
    Zhang K; An R; Gao Z; Zhang Y; Aruva MR
    Nucl Med Biol; 2006 May; 33(4):505-12. PubMed ID: 16720242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide.
    Kuhnast B; Bodenstein C; Haubner R; Wester HJ; Senekowitsch-Schmidtke R; Schwaiger M; Weber WA
    Nucl Med Biol; 2004 Apr; 31(3):337-44. PubMed ID: 15028246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.
    Nock BA; Maina T; Béhé M; Nikolopoulou A; Gotthardt M; Schmitt JS; Behr TM; Mäcke HR
    J Nucl Med; 2005 Oct; 46(10):1727-36. PubMed ID: 16204724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
    Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
    Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors.
    Orlova A; Rosik D; Sandström M; Lundqvist H; Einarsson L; Tolmachev V
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):314-23. PubMed ID: 17464277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.
    Orlova A; Tran T; Widström C; Engfeldt T; Eriksson Karlström A; Tolmachev V
    Int J Mol Med; 2007 Sep; 20(3):397-404. PubMed ID: 17671747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.
    Gourni E; Demmer O; Schottelius M; D'Alessandria C; Schulz S; Dijkgraaf I; Schumacher U; Schwaiger M; Kessler H; Wester HJ
    J Nucl Med; 2011 Nov; 52(11):1803-10. PubMed ID: 22045709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
    Wicki A; Wild D; Storch D; Seemayer C; Gotthardt M; Behe M; Kneifel S; Mihatsch MJ; Reubi JC; Mäcke HR; Christofori G
    Clin Cancer Res; 2007 Jun; 13(12):3696-705. PubMed ID: 17575235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.
    Wester HJ; Schottelius M; Scheidhauer K; Meisetschläger G; Herz M; Rau FC; Reubi JC; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):117-22. PubMed ID: 12483418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
    Sabbah EN; Kadouche J; Ellison D; Finucane C; Decaudin D; Mather SJ
    Nucl Med Biol; 2007 Apr; 34(3):293-304. PubMed ID: 17383579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
    Zhang H; Chen J; Waldherr C; Hinni K; Waser B; Reubi JC; Maecke HR
    Cancer Res; 2004 Sep; 64(18):6707-15. PubMed ID: 15374988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of a
    Mikaeili A; Erfani M; Sabzevari O
    Nucl Med Biol; 2017 Nov; 54():10-17. PubMed ID: 28810154
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.